Cervical cancer vaccine (HPV vaccine)

Cervical (cervix)cancer is very closely related to human papilloma virus(HPV). The HPV virus is mostly transmitted by sexual contact.

< Although there are many types of the HPV virus, vaccines have only been developed against the most common types. There are 2 types of HPV vaccines in our country.

HPV vaccine is a protective vaccine and does not have therapeutic properties. If vaccinated before encountering the virus, protection is close to 100%. HPV types 16 and 18 are associated with a 70% rate of cervical cancer. HPV types 11 and 16 are the cause of 90% of condylomas (genital warts).

HPVvaccine is currently recommended for women between the ages of 9-26 in our country. Whether women are married or single, whether they have had sexual experience before, or whether they have more than one partner does not change the vaccination. Currently, there are countries in the world that use vaccines up to the age of 55. However, as age progresses and the number of sexual partners increases, the effectiveness of the vaccine decreases.

Gardasilat 0.2 and 6 months
Cervarix0.1 and It is administered intramuscularly in the 6th month.

Since the effects of the vaccine on pregnant women and babies are not fully known, the vaccine should not be administered during pregnancy and while breastfeeding. .Vaccination for men is recommended in some countries, but this practice has not been implemented in our country yet.

Rarely, pain at the application site, swelling, redness, and systemically, as with any vaccine, dizziness, fatigue, blackout, fever and nausea may occur. Vaccination and smear

Having the vaccine does not eliminate cervical smear follow-up. Since the HPV virus is not the only cause of cervical cancer, annual smear screening should be performed.

Read: 0

yodax